- 专利标题: IMIDE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE
-
申请号: US17484628申请日: 2021-09-24
-
公开(公告)号: US20220089570A1公开(公告)日: 2022-03-24
- 发明人: Andrew P. CREW , Craig M. CREWS , Hanqing DONG , Meizhong JIN , Yimin QIAN , Jing WANG
- 申请人: Arvinas Operations, Inc.
- 申请人地址: US CT New Haven
- 专利权人: Arvinas Operations, Inc.
- 当前专利权人: Arvinas Operations, Inc.
- 当前专利权人地址: US CT New Haven
- 主分类号: C07D401/14
- IPC分类号: C07D401/14 ; C12N9/12 ; C12N9/18 ; A61K45/06 ; C12Q1/25 ; A61K31/4439 ; A61K31/519 ; A61K31/513 ; A61K47/54 ; A61K47/66
摘要:
The description relates to imide-based compounds, including bifunctional compounds comprising the same, which find utility as modulators of targeted ubiquitination, especially inhibitors of a variety of polypeptides and other proteins which are degraded and/or otherwise inhibited by bifunctional compounds according to the present invention. In particular, the description provides compounds, which contain on one end a ligand which binds to the cereblon E3 ubiquitin ligase and on the other end a moiety which binds a target protein such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of that protein. Compounds can be synthesized that exhibit a broad range of pharmacological activities consistent with the degradation/inhibition of targeted polypeptides of nearly any type.
信息查询